Search results
years: 50 mg PO qDay initially; May increase by 50 mg qDay at 1-week intervals to no more than 200 mg qDay; give qHS if somnolence experienced SSRI Lexapro,
SSRIs and SNRIs for children and adolescents with MDD and/or anxiety disorders are neither a panacea nor contra-indicated. The best available evidence suggests that fluoxetine may be the medication of choice for use in both MDD and anxiety disorders.
1 lis 2013 · SSRI medications can be effective in treating child and adolescent depression and anxiety disorders. Untreated depressive illness may be more harmful than appropriate use of SSRI medication. Physicians should ensure careful elicitation and documentation of baseline depressive and anxious symptoms before initiating SSRI medication.
6 gru 2019 · Selective serotonin reuptake inhibitors (SSRIs) are a first-line pharmacologic intervention for major depressive and anxiety disorders, but also are indicated for obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder, and bulimia nervosa, among other psychiatric conditions.
18 maj 2020 · As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable empirical support as safe and effective short-term treatments for anxiety in children and adolescents.
This article addresses a key question on the use of selective serotonin reuptake inhibitors (SSRIs) among children and adolescents. As briefly reviewed, recent randomized controlled trials have established the safety and efficacy of SSRIs in the acute treatment of major depression and anxiety disord ….
14 sie 2024 · SSRIs that have been studied and used in children and adolescents with major depressive disorder include fluoxetine (brand name: Prozac), citalopram (brand name: Celexa), escitalopram (brand name: Lexapro), fluvoxamine (brand name: Luvox), paroxetine (brand name: Paxil), and sertraline (brand name: Zoloft). Fluoxetine has been more widely ...
